• Survey Resource Center

    Survey Resource Center

    View survey results, compare data and see lab profiles. For members only.
Our Work

APHL offers resources to  assure the quality and sustainability of public health laboratory systems.


Featured Resources

 

 

Locate sources of fundinghttp://redesign.dev.aphl.org/member_resources/Lists/Highlighted Content/DispForm.aspx?ID=3Locate sources of funding<img alt="" src="/PublishingImages/Member-Resources-4.gif" style="BORDER:0px solid;" />http://redesign/rfp, /rfp
Find positions in your fieldhttp://redesign.dev.aphl.org/member_resources/Lists/Highlighted Content/DispForm.aspx?ID=2Find positions in your field<img alt="" src="/PublishingImages/Member-Resources-3.gif" style="BORDER:0px solid;" />http://careers.aphl.org/home/index.cfm?site_id=249, http://careers.aphl.org/home/index.cfm?site_id=249
Resources from labs for labshttp://redesign.dev.aphl.org/member_resources/Lists/Highlighted Content/DispForm.aspx?ID=1Resources from labs for labs<img alt="" src="/PublishingImages/Member-Resources-2.gif" style="BORDER:0px solid;" />http://redesign/MRC/Pages/default.aspx, /MRC/Pages/default.aspx

 

 

2015 All-Hazards Survey Reporthttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/PHPR-2015-All-Hazards-52016-digital.pdf2015 All-Hazards Survey ReportEach year, APHL surveys PHLs to assess their readiness to respond to threats and identify challenges that affect rapid response. This year's survey covers the 12-month period from 7/1/14 - 6/30/15, representing FY14 CDC PHEP Cooperative Agreement, BP 3.
Guidance for State Medical Cannabis Testinghttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/EH-Guide-State-Med-Cannabis-052016.pdfGuidance for State Medical Cannabis Testing
MTBC Drug Susceptibility Testing: EMBhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-MTBC_DrugSusceptibility_0216.pdfMTBC Drug Susceptibility Testing: EMBA discussion of issues surrounding the use of the anti-tuberculosis drug Ethambutol, or EMB, including recommended dose, EMB drug susceptibility testing and test methods, and reproducibility of susceptibility testing for EMB.
MTBC Drug Susceptibility Testing: PZAhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-PZA_WhitePaper_0216.pdfMTBC Drug Susceptibility Testing: PZAA discussion about the use of Pyrazinimide, or PZA, as first-line therapy for treatment of Mycobacterium tuberculosis complex, including mechanism of action, reproducibility of susceptibility testing, and impact on clinical outcomes.